Welcome!

News Feed Item

Global Market for Blood Banking and Blood Products Projected to reach $43 billion by 2018; Spectrometers and Fluorometers to Reach $18.4 bn; Anticoagulants to Reach $12.9 bn; Cell and Tissue Culture Supplies to Reach $5.6 bn

FARMINGTON, Conn., Nov. 6, 2012 /PRNewswire-iReach/ -- Four innovating life science fields to keep an eye on include blood banking, spectrometry, anticoagulants, and cell and tissue culture. Thanks to an aging population and a steep increase in healthcare expenditures among other trends, these markets are on the rise.

(Photo: http://photos.prnewswire.com/prnh/20121106/CG07120)

Global Information Inc (GII) presents four innovative life science market research reports from our premium research partner Global Industry Analysts, Inc. These global strategic business reports provide market forecasts, profile key companies and players, and review mergers, acquisitions and other strategic industry activities related to the dynamic markets for spectrometers, cell and tissue cultures, anticoagulants and blood banking.

Spectrometers and Spectrophoto/Fluorometers

Spectroscopic instruments are the swiss army knife of laboratories – they perform diverse tasks such as monitoring processes, identifying compounds and elucidating chemical structures. Driven by rising sales of instrument systems by laboratories, the market for spectroscopy instruments recovered in 2010 and experienced a strong resurgence in 2011 and is project to reach $18.4 billion by the year 2018.

Developed markets such as the United States, Europe and Japan account for a predominant share of the global market for spectrometers and spectrophoto/fluorometers. Despite the continued dominance of developed regions, emerging economies specifically in Asia-Pacific, such as India and China, and Latin America are expected to offer newer opportunities owing to the different economics as well as application needs.

In the long run, demand from industries such as metals, chemicals and automotive is expected to continue driving growth in the spectroscopy market. Advancements in the areas of drug discovery and development, metabolomics, pharmacogenomics, and expanded application markets bode well for the future of spectroscopy market. Above average demand is also expected from security and defense industries; research targeted at discovery and use of new materials as well as continued growth in applications suitable for use in the life sciences market. Advanced spectrometers of the future will target the emerging demands of areas such as mineralogy, medicine, environment, pharmaceuticals and biochemistry.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/go134266-spectrometers.html

Cell/Tissue Culture Supplies

The global market for Cell/Tissue Culture Supplies is projected to reach US$5.6 billion by 2018, driven by advances in biotechnology and life science research coupled with broader range of application areas. Going forward, the market for Cell/Tissue Culture Supplies is expected to grow at an impressive pace, fueled by heightened interest in biopharmaceutical therapeutics, human and veterinary vaccine applications, and growing success of industrial biopharmaceuticals.

The evolution of cell culture technologies witnessed the successful incorporation of a number of segments such as cell biology, genetic engineering, protein chemistry, genomics and chemical engineering into the cell culture field, thus serving to enrich the cell/tissue culture domain. Growing awareness about applications of biotherapeutics is driving the market for products from cell cultivation. Cells play a major role in the development of biopharma drugs such as therapeutic enzymes, monoclonal antibodies (mABs), interferons, vaccines, thrombolytics, blood factors and hormones for treating life-threatening diseases.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/go138765-cell-tissue-culture.html

Anticoagulants

The anticoagulants market has come a long way since the 1990s. With thrombosis emerging as one of the major causes of death in various countries across the world, regulation of blood clotting has become one of the key areas of focus in the medical fraternity in recent times. The global market for anticoagulants is projected to reach US$12.9 billion by the year 2018, primarily driven by growing population at the risk of thrombosis. Aging population, rising incidence of cardiovascular diseases, acute hip and knee complications and the emergence of novel oral therapeutics also comprise the key factors supporting market growth.

This report provides a comprehensive review of trends, review of new drugs, indications, comparative data on select drugs, drug development pipeline, product approvals/introductions, strategic industry activities and profiles of major companies worldwide. Major players profiled in the report include Bayer Healthcare AG, Boehringer Ingelheim, Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Sanofi, and Teva Pharmaceutical Industries Ltd., among others.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/go138649-anticoagulants.html

Blood Banking and Blood Products

The global market for Blood Banking and Blood Products is projected to reach US$43 billion by 2018, driven by health scares and regulatory requirements. Worldwide market for Blood Banking and Blood Products is exhibiting a healthy trend, thanks to an aging population, and a steep increase in healthcare expenditures.

Though temporarily impacted by the economic recession, new infections continue to take a toll on population in developing nations, fueling demand for blood banking and blood products. Regulatory and healthcare bodies across the world, in a bid to serve these people, are adopting stringent policies relating to blood safety. As an extension to this, manufacturers all over the world are developing improved, safer, and advanced blood banking technologies for the collection, processing and delivery of blood products.

An Executive Summary for this report and free sample pages from the full document are available at http://www.giiresearch.com/report/go136179-blood-banking.html

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Yuko Ueki Global Information, Inc., 860-674-8796, [email protected]

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Global Information Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Everything run by electricity will eventually be connected to the Internet. Get ahead of the Internet of Things revolution. In his session at @ThingsExpo, Akvelon expert and IoT industry leader Sergey Grebnov provided an educational dive into the world of managing your home, workplace and all the devices they contain with the power of machine-based AI and intelligent Bot services for a completely streamlined experience.
"This week we're really focusing on scalability, asset preservation and how do you back up to the cloud and in the cloud with object storage, which is really a new way of attacking dealing with your file, your blocked data, where you put it and how you access it," stated Jeff Greenwald, Senior Director of Market Development at HGST, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
"Venafi has a platform that allows you to manage, centralize and automate the complete life cycle of keys and certificates within the organization," explained Gina Osmond, Sr. Field Marketing Manager at Venafi, in this SYS-CON.tv interview at DevOps at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Creating replica copies to tolerate a certain number of failures is easy, but very expensive at cloud-scale. Conventional RAID has lower overhead, but it is limited in the number of failures it can tolerate. And the management is like herding cats (overseeing capacity, rebuilds, migrations, and degraded performance). In his general session at 18th Cloud Expo, Scott Cleland, Senior Director of Product Marketing for the HGST Cloud Infrastructure Business Unit, discussed how a new approach is neces...
Cloud-enabled transformation has evolved from cost saving measure to business innovation strategy -- one that combines the cloud with cognitive capabilities to drive market disruption. Learn how you can achieve the insight and agility you need to gain a competitive advantage. Industry-acclaimed CTO and cloud expert, Shankar Kalyana presents. Only the most exceptional IBMers are appointed with the rare distinction of IBM Fellow, the highest technical honor in the company. Shankar has also receive...
"We're developing a software that is based on the cloud environment and we are providing those services to corporations and the general public," explained Seungmin Kim, CEO/CTO of SM Systems Inc., in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Business professionals no longer wonder if they'll migrate to the cloud; it's now a matter of when. The cloud environment has proved to be a major force in transitioning to an agile business model that enables quick decisions and fast implementation that solidify customer relationships. And when the cloud is combined with the power of cognitive computing, it drives innovation and transformation that achieves astounding competitive advantage.
Personalization has long been the holy grail of marketing. Simply stated, communicate the most relevant offer to the right person and you will increase sales. To achieve this, you must understand the individual. Consequently, digital marketers developed many ways to gather and leverage customer information to deliver targeted experiences. In his session at @ThingsExpo, Lou Casal, Founder and Principal Consultant at Practicala, discussed how the Internet of Things (IoT) has accelerated our abilit...
Leading companies, from the Global Fortune 500 to the smallest companies, are adopting hybrid cloud as the path to business advantage. Hybrid cloud depends on cloud services and on-premises infrastructure working in unison. Successful implementations require new levels of data mobility, enabled by an automated and seamless flow across on-premises and cloud resources. In his general session at 21st Cloud Expo, Greg Tevis, an IBM Storage Software Technical Strategist and Customer Solution Architec...
Five years ago development was seen as a dead-end career, now it’s anything but – with an explosion in mobile and IoT initiatives increasing the demand for skilled engineers. But apart from having a ready supply of great coders, what constitutes true ‘DevOps Royalty’? It’ll be the ability to craft resilient architectures, supportability, security everywhere across the software lifecycle. In his keynote at @DevOpsSummit at 20th Cloud Expo, Jeffrey Scheaffer, GM and SVP, Continuous Delivery Busine...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...
In his session at Cloud Expo, Alan Winters, U.S. Head of Business Development at MobiDev, presented a success story of an entrepreneur who has both suffered through and benefited from offshore development across multiple businesses: The smart choice, or how to select the right offshore development partner Warning signs, or how to minimize chances of making the wrong choice Collaboration, or how to establish the most effective work processes Budget control, or how to maximize project result...
"Software-defined storage is a big problem in this industry because so many people have different definitions as they see fit to use it," stated Peter McCallum, VP of Datacenter Solutions at FalconStor Software, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
"Our strategy is to focus on the hyperscale providers - AWS, Azure, and Google. Over the last year we saw that a lot of developers need to learn how to do their job in the cloud and we see this DevOps movement that we are catering to with our content," stated Alessandro Fasan, Head of Global Sales at Cloud Academy, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
Data is the fuel that drives the machine learning algorithmic engines and ultimately provides the business value. In his session at Cloud Expo, Ed Featherston, a director and senior enterprise architect at Collaborative Consulting, discussed the key considerations around quality, volume, timeliness, and pedigree that must be dealt with in order to properly fuel that engine.